个性化血栓预防:从固定的剂量到有针对性的低分子量肝素使用
Ourania S Kotsiou1,2, Dimos Charalampidis3, Konstantinos N Malizos4
1Laboratory of Human Pathophysiology, School of Health Sciences, Department of Nursing, University of Thessaly, Larissa, Greece. raniakotsiou@gmail.com.
Cardiovascular drugs and therapy
|November 13, 2025
概括
以抗Xa (抗Xa) 水平为指导的个性化低分子量肝素 (LMWH) 剂量可以改善静脉血栓塞栓症 (VTE) 预防. 抗Xa监测优化了LMWH治疗,特别是在高风险患者中,但需要进一步标准化.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血栓形成研究研究
- 临床医学 临床医学
背景情况:
- 静脉血栓塞栓症 (VTE) 是术后并发症的主要原因.
- 标准的低分子量肝素 (LMWH) 剂量往往无法达到治疗性抗Xa因子 (anti-Xa) 水平.
- 特定于患者的因素需要个性化抗凝剂策略.
研究的目的:
- 审查使用抗Xa指导剂量的个性化LMWH血栓预防的证据.
- 评估抗Xa引导LMWH的临床有效性和实施挑战.
- 评估LMWH在各种患者环境中的疗效.
主要方法:
- 系统的文献审查.
- 包括对固定剂量,基于体重和抗Xa调整的LMWH的研究.
- 在创伤,手术,重症监护和瘤病人的队列中进行分析.
主要成果:
- 在高达87.7%的固定剂量LMWH患者中观察到亚治疗性抗Xa水平.
- 抗Xa指导剂量改善了预防水平的达到,并减少了静脉瘤发病率.
- 随着剂量调整,主要出血事件没有显著增加.
- 研究设计异质性和小样本大小限制了采用.
结论:
- 通过抗Xa监测进行个性化LMWH剂量测定,对精选的患者显示出有前途.
- 标准化测试和前性验证对于临床实施至关重要.
- 抗Xa指导疗法为VTE预防提供了个性化的方法.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care
254
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
254
Dosage Regimen: Individualization
146
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
146
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
185
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
185


